Monday, August 12, 2013 1:18:28 PM
That is an amusing and quite absurd point of view. If you aren't going to invest on what the FDA does, then you can't invest in ANY biotech. Patent issues and court cases occur all the time during drug development and after FDA approval. Hell, ONXX sued Bayer over Regorafenib (now Stivarga), a Nexavar knockoff that Bayer tried to sneak in without ONXX's knowledge. Guys like you were assuring ONXX shareholders like myself that ONXX could never win and Bayer would crush them. That was when ONXX was inthe low $20s. ONXX prevailed and forced Bayer to settle.
{{Everyone here kept on counting about how much Amphastar and Watson were going to owe Momenta and not one person here would even consider the fact that it could be Momenta/NVS that would have to write the check. I brought it up repeatedly and was laughed at.}}
No, not everyone, but you keep trying to distort reality if you feel the need to.
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
